Yourgene Health PLC shares rose 9.5% in early Monday trading following an announcement the company would be supporting a deal between pharmacy chain Boots and partner MyHealthChecked PLC (AIM:MHC).
Boots will stock MyHealthChecked DNA swab tests under the deal, with five out of the 14 variants of these set to be processed at Yourgene’s lab in Manchester.
“Yourgene is proud to continue to support MyHealthChecked with our state-of-the-art laboratory and the contract is a testament to the quality of the service we provide,” chief executive Lyn Rees said.
Yourgene shares rose 9.5% to 0.23p following the announcement, before later slipping back to 0.21p, a rise of 2%.